Blue Horseshoe Stocks: GNCA Review & More

OPTIONS REVIEW

We wrapped things up on Friday by going over some of our successes for the week,. and we also provided readers with a couple of quick strike options ideas for Friday’s session itself. It should come as no surprise, given the sheer numbers of winners we routinely unearth, that both of our ideas proved to be excellent chances to finish the week on a very high note.

Here are the ideas along with the total possible gains that could have been achieved on the day.

OKTA Weekly $111-113 Calls
$111 Calls – Range: 2.20-8.62  – Max Gain: 292%
$112 Calls – Range: 1.81-7.69 – Max Gain: 325%
$113 Calls – Range: 1.28-6.20 – Max Gain: 384%

BIG 06/21 $30-32.50 Calls
$30 Calls – Range: .15-.35   – Max Gain: 133%
$32.50 Calls – Range: .05-.15 – Max Gain: 200%
____

SPY OPTIONS:
If the SPY can break 275.27, we’ll be looking at the Weekly $275.50 Calls, and if it falls below 274.50, we’ll be tracking the Weekly $274 Puts.


Genocea Biosciences, Inc. GNCA

We originally began tracking GNCA in our very first report of the new year (01/02) and we wanted to follow up with it now, five months later, as we are very impressed with where the stock has ended up. The stock actually set its 2019 low of 2.50 on January 2nd and it hasn’t looked back since.

By the end of February, the stock had doubled to five dollars, and now, it has doubled again. This morning in premarket trading, we’ve witnessed a new of 12.22 from GNCA, representing an total rise of 388% over our observed low. We’re going to be very interested to see what it’s going to do in this newfound blue-sky territory.


Extended Watchlist:
AMPG, MRTX, CYTR, AIMT, TRVN, APL, HEB, FSM, MYT, IGLD, VSTM, LODE

Blue Horseshoe Stocks: AMPG News Alert

AmpliTech Group, Inc. AMPG – News Update

As you may be aware, we have been following AMPG closely for several weeks now, during which time we have witnessed the stock rise from a low of .043 on the morning of our initial report on on April 1st, to a high of .084 just this week! That’s an excellent upswing of 95% in just under two months’ time.

We wanted to post an update on AMPG this morning relating to the company’s most recent press release,which pertains to the company’s response to recent investor queries, in the form of a Q&A that we urge you to check out now:

Bohemia, NY, May 30, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — AmpliTech Group, Inc. (OTCQB: AMPG): Amplitech (AMPG) filed its Form 10-Q on May 14, 2019, and received some follow up questions from investors regarding its strategy. (>>READ Q&A)

As an added aside, we have been referring to AMPG as an undervalued stock from the outset of our coverage, and for what it’s worth, both the performance on the chart, and the consensus opinion at BARCHART.COM agrees with us. AMPG is presently receiving a 100% Long-Term “Buy” Rating, and an 80% “Buy” signal overall.


Options Reviews

Yesterday we took opposite stances on DG and PANW, for which we formulated a bullish and a bearish set of options ideas, respectively. We couldn’t have been more on the dot with these plays, which each produced single session gain opportunities of a significant nature.

We signaled the DG $122-124 Calls and the PANW $202.50-200 Puts and five out of five sets of contracts produced multibag runs on the day.

Dollar General Corp. DG $122-124 Calls

[[DATA LOST]]

Palo Alto Networks,Inc. PANW $202.50-200 Puts
$202.50 Puts – Range: 2.00-4.18  – Max Gain: 103%
$200 Puts – Range: 1.40-2.85 – Max Gain: 136%
_____

Fresh Options Ideas:
BIG 06/21 $30-32.50 Calls
OKTA Weekly $111-113 Calls*

*Never trade weekly options on a Friday unless you are an advanced level trader with access to disposable funds.


Extended Watchlist:
SBOT, MYOV, XRF, SCZ, BAS, ELTK

Blue Horseshoe Stocks: Huge Recent Success

Progressive Care, Inc. RXMD

Even though much of our focus over the past couple of years has turned to short term options trading, penny stocks have always been our bread and butter, and RXMD is an example of one that we’ve found incredible success with of late.

After appearing in our morning reports every single day this week as it streaked into blue skies, RXMD once again registered a new 5-year high of .213 yesterday. From Monday’s low of .1171 it marked an intraweek upswing of 82%

As we’ve mentioned several times now, we had the chance to get into RXMD as low as .0663 following our initial alert on February 22nd, and from that point, yesterday’s high represented an increase of 221% over a period of eleven trading days.

__________

Rennova Health, Inc. RNVA

Also in the penny stock arena, we did well with RNVA this week, including it in Tuesday’s premarket report. From a subpenny low of .006, the stock made a 200% move to yesterday’s high of .018, and it’s gone even higher in the premarket this morning.


Zosano Pharma Corp. ZSAN

After tagging ZSAN as a bottom-bounce play on Friday, at which time is was trading for as little as 6.8175, we’ve witnessed an explosion this week. This play has also appeared in three out of our last five reports as it has absolutely taken off.

Yesterday morning, we pointed out that despite already making significant gains, if it broke an area of key resistance we highlighted on the chart, that things could get interesting and they certainly did.

ZSAN exploded from a low of 12.57 and ran as high as 25.70, an intraday move of 104% an a mind-bending 275% over a period of just a few days. That’s fantastic for a stock that started out above six dollars!


Fresh Options Idea: SPY Weekly $274.50-277 Calls*

*Do NOT trade weekly calls on a Friday unless you are an expert level trader!


Extended Watchlist:
NTLA, OKTA, THO, MARA, NVCN, YY, ONCS, CRIS, TEUM